Log In
Print this Print this

miRInform Thyroid

  Manage Alerts
Collapse Summary General Information
Company Asuragen Inc.
DescriptionPanel of 17 molecular markers, including 14 DNA mutations and 3 RNA translocations, used in conjunction with ultrasound-guided fine needle aspirate (FNA) biopsies
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsImprove preoperative diagnostic accuracy of indeterminate thyroid nodules and aid in characterization of malignancy; Manage patients with thyroid nodules
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today